BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2026.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 111144
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.111144
Table 1 Comparison of Kupffer phase contrast-enhanced ultrasonography parameters between well-differentiated and poorly differentiated hepatocellular carcinoma lesions and identification of independent predictors of tumor differentiation, n (%)/mean ± SD
VariableUnivariate analysis
Multivariate analysis
Well-differentiation (n = 137)
Poor differentiation (n = 102)
P value
OR
95%CI
P value
Clinicopathologic features
    Males126 (92.0)86 (84.3)0.064
    Age, year56 ± 1154 ± 120.138
    HBsAg-positive113 (82.5)87 (85.3)0.447
    AFP ≥ 7 ng/mL67 (48.9)81 (79.4)0.0002.7991.334-5.8710.006
    Ki-67 expression level73 (53.3)83 (81.4)0.000
    Vascular invasion34 (24.8)48 (47.1)0.001
US features
    Tumor size (cm)4.3 ± 2.55.4 ± 2.90.0031.0550.931-1.1960.397
    Cirrhosis84 (59.2)58 (40.8)0.488
    AP (hyper, iso, hypo-enhancement)134, 3, 098, 3, 10.474
    PVP (hyper, iso, hypo-enhancement)10, 84.436, 69, 270.599
    DP (hyper, iso, hypo-enhancement)1, 16, 1200, 11, 910.669
    KP (hyper, iso, hypo-enhancement)1, 2, 1340, 2, 1000.660
CEUS
Arterial phase
    OT (second)15.0 ± 3.015.2 ± 3.80.660
    PT (second)24.9 ± 5.424.7 ± 6.60.835
    RT (second)9.9 ± 3.69.5 ± 4.30.424
    PIAV (second)34.2 ± 5.833.0 ± 6.70.151
Kupffer phase
    EIAV (dB)52.4 ± 5.354.1 ± 5.30.0150.9450.869-1.0270.183
    ID (dB)6.9 ± 4.312.2 ± 4.80.0001.0480.862-1.2730.636
    IR1.127 ± 0.1141.299 ± 0.1370.000110887.3081121-1011632170.001
Table 2 Diagnostic performance of variables
Variable
Cut-off value
Sensitivity (%)
Specificity (%)
AUC
AFP (ng/mL)97.6957.483.60.739
Tumor size (cm)4.6553.970.80.610
EIAV (dB)56.38440.278.10.590
ID (dB)9.18480.474.50.815
IR1.21582.486.90.877